Chemomab Therapeutics

CMMB

Börsenwert 11,5 Mio. $

#	Name	Position	Handelswert	Veränderung Aktien	Anteils- änderung
1	1 OrbiMed New York	9,5 Mio. $	–	–	–
2	2 Cormorant Asset Management Boston, Massachusetts	1,07 Mio. $	–	–	–
3	3 Ikarian Capital Dallas, Texas	992.000 $	–	–	–
4	4 Boothbay Fund Management New York	153.000 $	–	–	–
5	5 State Street Boston, Massachusetts	134.000 $	+2.703 $	+194	+2 %
6	6 Meitav Investment House Bene-Beraq, Israel	129.000 $	–	–	–
7	7 Envestnet Asset Management Chicago, Illinois	45.000 $	+4.821 $	+346	+13 %
8	8 Geode Capital Management Boston, Massachusetts	43.000 $	–	–	–
9	9 Advisory Services Network Atlanta, Georgia	41.000 $	+38.913 $	+2.793	Neu
10	10 Osaic Holdings Scottsdale, Arizona	29.000 $	+2.034 $	+146	+8 %
11	11 Morgan Stanley New York	21.000 $	+19.491 $	+1.399	Neu
12	12 Urban Wealth Management El Segundo, California	10.000 $	+9.627 $	+691	Neu
13	13 Newbridge Financial Services Group Boca Raton, Florida	4.000 $	–	–	–
14	14 Royal Bank of Canada Toronto, Ontario, Canada	1.000 $	-42 $	-3	-5 %
15	15 CAPTRUST Financial Advisors Raleigh, North Carolina	1.000 $	–	–	–
16	16 Renaissance Technologies New York	–	-134.000 $	-6.990	Geschlossen
17	17 UBS Group Zurich, Switzerland	–	-4.000 $	-221	Geschlossen
18	18 ARK Investment Management St. Petersburg, Florida	–	-4.000 $	-198	Geschlossen
19	19 JP Morgan Chase New York	–	-4.000 $	-188	Geschlossen